New CDC data: Osteoporosis rates increase in women … Exposed to COVID? Study finds point-of-care antibody tests highly effective at detection … Ruined J&J coronavirus vaccine doses are not in circulation:...
Clinical briefs for Tuesday, April 6
By
Alicia Lasek
Apr 06, 2021
COVID outbreak among vaccinated assisted living residents under investigation … FDA rejects bid to approve Nuplazid for treatment of dementia-related psychosis … J&J betting $780M on long-acting antiviral...
Clinical briefs for Wednesday, March 17
By
Alicia Lasek
Mar 17, 2021
Senior living giant sued over handling of transfers and discharges … First COVID vaccine dose 63% effective in nursing home study … FDA hedges against gene variants: Requires COVID antibody drugmakers...
Anticipating B117 surge, experts urge continued focus on elders, deferred 2nd vaccine doses
By
Alicia Lasek
Mar 18, 2021
Infectious disease and vaccine experts have laid out a plan for thwarting yet another uptick in transmission and illness. A new surge is likely by the end of April, they say in a CIDRAP report.
Robust response to virus variants expected in former COVID patients and the vaccinated
By
Alicia Lasek
Mar 31, 2021
Blood samples from recovered COVID-19 patients show that they and their vaccinated peers should be able to fend off the virus and its variants in future encounters, NIH researchers say.
November’s drop in COVID deaths may hint at early nursing home success, experts contend
By
Alicia Lasek
Mar 16, 2021
Between spring pandemic lockdowns and November, mortality rates due to COVID-19 in nursing homes declined significantly — well before a vaccine was approved to treat the disease, according to a new study.
J&J’s COVID-19 vaccine 74 percent effective, real-world study finds
By
Alicia Lasek
Nov 04, 2021
Data from more than 8,800 vaccinated Mayo Clinic patients has found that a single dose of Johnson & Johnson’s COVID-19 vaccine reduces hospitalization in the face of widely circulating gene variants.
COVID vaccines lost some effectiveness in delta surge, ongoing CDC study finds
By
Alicia Lasek
Aug 25, 2021
The three federally sanctioned COVID vaccines have lost a “moderate” amount of effectiveness against SARS-CoV-19 ever since the delta gene variant became the predominant U.S. strain, the agency reports.
Immune system boost is reason not to skip second COVID-19 shot, study finds
By
Liza Berger
Jul 20, 2021
The second dose of a COVID-19 vaccine offers a serious boost to a part of the immune system that provides broad antiviral protection, according to a Stanford University School of Medicine study. This finding...
Feds gauging threat to vaccine, test and treatment efficacy in face of omicron variant
By
Alicia Lasek
Dec 01, 2021
The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.
